@article{edeline:hal-01146933,
TITLE = {Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors},
AUTHOR = {Edeline, Julien and Crouzet, Laurence and Le Sourd, Samuel and Larible, Claire and Brunot, Ang{\'e}lique and Le Roy, Florence and Cattenoz, Catherine and Latournerie, Marianne and Gedouin, Daniel and Guillygomarc'H, Anne and Boucher, Eveline},
URL = {https://univ-rennes.hal.science/hal-01146933},
JOURNAL = {Cancer Chemotherapy and Pharmacology},
PUBLISHER = {Springer Verlag},
VOLUME = {75},
NUMBER = {1},
PAGES = {215--219},
YEAR = {2015},
DOI = {10.1007/s00280-014-2645-z},
KEYWORDS = {Hepatocellular ; Comorbidity ; Drug Interactions ; Venous Thrombosis ; Survival Analysis ; Antineoplastic Agents ; 80 and over ; Aging ; Humans ; Incidence ; Hemorrhage ; France ; Retrospective Studies ; Platelet Aggregation Inhibitors ; Portal Vein ; Tumor Burden ; Carcinoma ; Asthenia ; Aged ; Follow-Up Studies ; Drug Monitoring ; Female ; Male ; Liver Neoplasms ; Phenylurea Compounds ; Niacinamide ; Liver},
HAL_ID = {hal-01146933},
HAL_VERSION = {v1},
}